Search Results 1291-1300 of 19424 for Hemoglobin

  1. Stereotactic Body Radiation Therapy in Treating Patients with Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable); If liver metastases ...

  2. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

    Hemoglobin (Hgb) < 10 g/dL; Aspartate aminotransferase (AST), alanine aminotransferase (ALT), or alkaline phosphatase > 2 x the Upper Limit of Normal (ULN); ...

  3. A Study of Nab-Paclitaxel as Maintenance Treatment After Cisplatin-Based Chemotherapy and Surgery for Patients with High-Risk Bladder Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 mg/dL; Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 2.5 x ULN; Alkaline phosphatase ...

  4. Examination of the Pancreas in New-onset Diabetes - Mayo Clinic

    Participation eligibility · Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values. HbA1C ≥ 6.5% · No acute illness or ...

  5. A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/​A011-16) - Mayo Clinic

    * Hemoglobin (Hgb) above the gender-specific upper limit of normal (ULN) per local laboratory test within 28 days of Visit 1or \<10 g/dL per local ...

  6. SC16LD6.5 in Recurrent Small Cell Lung Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL; Serum bilirubin < 1.5 x ULN; AST/ALT (SGOT/SGPT) < 2.5 x ULN for the reference laboratory or < 5 x ULN in the presence of liver ...

  7. A Feasibility Study To Evaluate The Safety Of The TheraSphere Glioblastoma (GBM) Device In Patients With Recurrent GBM - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL. 13. Have a negative pregnancy test within 14 days prior to registration on study (for FOCBP, female of child-bearing potential) 14 ...

  8. Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Mayo Clinic

    Hemoglobin ≥ 9 g/dL; Bilirubin ≤ 1.5 times upper limit of normal (ULN); Creatinine ≤ 1.5 times ULN; No uncontrolled high blood pressure; No unstable angina ...

  9. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9 g/dL;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN);; Aspartate transaminase (AST) and alanine aminotransferase (ALT) ≤ 2.5 x ...

  10. A Study To Evaluate Intravenous Iloprost In Subjects With Symptomatic Raynaud's Phenomenon Secondary To Systemic Sclerosis - Mayo Clinic

    ... hemoglobin). Subjects with scleroderma renal crisis within 6 months of screening. Subjects with a concomitant life-threatening disease with a life ...